• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.13%

    Seattle Genetics, Inc. (SGEN)

    -NasdaqGS
    45.52 Up 2.13(4.91%) 4:00PM EDT
    |After Hours : 45.70 Up 0.18 (0.40%) 4:54PM EDT
    Add to Portfolio
    Prev Close:43.39
    Open:43.22
    Bid:45.40 x 200
    Ask:46.33 x 100
    1y Target Est:45.90
    Beta:2.36
    Earnings Date:Jul 29 - Aug 3 (Est.)
    Day's Range:42.80 - 46.44
    52wk Range:30.05 - 46.44
    Volume:1,637,106
    Avg Vol (3m):1,143,080
    Market Cap:5.68B
    P/E (ttm):N/A
    EPS (ttm):-0.66
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SGEN

    Comparison

    Symbol% ChgMkt Cap
    SGENUp 4.91%5.68B
    IMGNDown 9.13%1.21B
    PFEDown 0.20%212.38B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):18.02
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.77
    Quarterly EPS Est (Jun-15) :-0.21
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):-3.24

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Seattle Genetics, Inc., a biotechnology company, develops and commercializes antibody-based therapies for the treatment of cancer. The company is developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback